To better distinguish between tumor extent and normal tissues, PET/CT using tracers that bind specifically to somatostatin receptor type 2 (SSTR2), commonly expressed by these tumors, can be used in addition to MRI. This evidence concerns the gene SSTR2 and neoplasm.